Report cover image

NA Pterygium Drug Market - Industry Trends and Forecast to 2029

Publisher Data Bridge Market Research
Published Jun 01, 2022
Length 185 Pages
SKU # DAABD17292590

Description

NA Pterygium Drug Market - Industry Trends and Forecast to 2029

The North America pterygium drug market is projected to register a substantial CAGR of 5.8% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.
Market Segmentation
North America Pterygium Drug Market, By Type (Progressive Pterygium and Atrophic Pterygium), Stages (Stage 2, Stage 3, Stage 1, Stage 4), Treatment (Artificial Tears/Topical Lubricants and Steroid Eye Drops.), Formulation (Eye Drops, Eye Ointments, Others), Mode of Purchase (Prescription and Over the Counter (OTC)), Population Type (Geriatric and Adults), End-User (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the North America pterygium drug market are:
• Increase in healthcare awareness to reduce the risk of eye illnesses
• Rising geriatric population

Market Players

Some of the major players operating in the North America pterygium drug market are:
• Johnson & Johnson Services, Inc.
• Novartis AG
• Akorn Operating Company LLC
• Bausch & Lomb Incorporated
• AbbVie Inc.
• Prestige Consumer Healthcare Inc.
• Sylentis
• Bayer AG
• Zydus Group
• Amneal Pharmaceuticals LLC
• OASIS Medical
• Alcon
• Santen Pharmaceutical Co.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

185 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America Pterygium Drug Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 North America Pterygium Drug Market: Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Class Segment Lifeline Curve
2.8 Dbmr Market Position Grid
2.9 Vendor Share Analysis
2.10 Market End User Coverage Grid
2.11 Secondary Sources
3 Executive Summary
4 Premium Insights
4.1 Pestel's Model
4.2 Porter's 5 Forces
4.3 North America Pterygium Drug Market: Number Of Surgeries
5 Epidemiology
6 Pipeline Analysis
7 North America Pterygium Drug Market: Regulations
7.1 Regulation In The U.S.
7.2 Regulation In Europe:
7.3 Regulations In China:
7.4 Regulations In India:
7.5 Relevant Acts For This Framework:
8 Market Overview
8.1 Drivers
8.1.1 Rise In Incidences And Prevalence Of Ophthalmic Disorders
8.1.2 Rise In Geriatric Population
8.1.3 Increase In Healthcare Awareness To Reduce The Risk Of Eye Illnesses
8.2 Restraints
8.2.1 High Cost Of Eye Treatment And Medication
8.2.2 Side Effects Of Steroids Eye Drops
8.3 Opportunities
8.3.1 Programs And Initiatives To Reduce The Burden Of Eye Diseases
8.3.2 Rise In Healthcare Expenditure And Disposable Income
8.3.3 Increase In Research And Development Activities
8.4 Challenges
8.4.1 Stringent Rules & Regulations
8.4.2 Exposure To Ultraviolet Radiations
9 North America Pterygium Drug Market, By Disease Type
9.1 Overview
9.2 Progressive Pterygium
9.3 Atrophic Pterygium
10 North America Pterygium Drug Market, By Stages
10.1 Overview
10.2 Stage 2
10.3 Stage 3
10.4 Stage 1
10.5 Stage 4
11 North America Pterygium Drug Market, By Treatment
11.1 Overview
11.2 Artificial Tears/Topical Lubricants
11.2.1 Demulcent
11.2.2 Emollients
11.3 Steroid Eye Drops
11.3.1 Ketone Steroids
11.3.1.1 Prednosolone
11.3.1.2 Dexamethasone
11.3.1.3 Flurometholone
11.3.1.4 Others
11.3.2 Ester Steroid (Loterprednol)
12 North America Pterygium Drug Market, By Formulation
12.1 Overview
12.2 Eye Drops
12.2.1 Eye Drops With Preservatives
12.2.2 Preservative-free Eye Drops
12.3 Eye Ointments
12.4 Others
13 North America Pterygium Drug Market, By Mode Of Purchase
13.1 Overview
13.2 Prescription
13.3 Over The Counter (Otc)
14 North America Pterygium Drug Market, By Population Type
14.1 Overview
14.2 Geriatric
14.3 Adults
15 North America Pterygium Drug Market, By End User
15.1 Overview
15.2 Hospitals
15.3 Specialty Clinics
15.4 Home Healthcare
15.5 Others
16 North America Pterygium Drug Market, By Distribution Channel
16.1 Overview
16.2 Retail Pharmacies
16.3 Hospital Pharmacies
16.4 Online Pharmacies
16.5 Others
17 North America Pterygium Drug Market, By Region
17.1 North America
17.1.1 U.S.
17.1.2 Mexico
17.1.3 Canada
18 North America Pterygium Drug Market: Company Landscape
18.1 Company Share Analysis: North America
19 Swot Analysis
20 Company Profiles
20.1 Alcon
20.1.1 Company Snapshot
20.1.2 Recent Financials
20.1.3 Company Share Analysis
20.1.4 Product Portfolio
20.1.5 Recent Developments
20.2 Abbvie Inc.
20.2.1 Company Snapshot
20.2.2 Revenue Analysis
20.2.3 Company Share Analysis
20.2.4 Product Portfolio
20.2.5 Recent Development
20.3 Bausch & Lomb Incorporated
20.3.1 Company Snapshot
20.3.2 Revenue Analysis
20.3.3 Company Share Analysis
20.3.4 Product Portfolio
20.3.5 Recent Development
20.4 Johnson & Johnson Services, Inc.
20.4.1 Company Snapshot
20.4.2 Revenue Analysis
20.4.3 Company Share Analysis
20.4.4 Product Portfolio
20.4.5 Recent Developments
20.5 Bayer Ag
20.5.1 Company Snapshot
20.5.2 Revenue Analysis
20.5.3 Company Share Analysis
20.5.4 Product Portfolio
20.5.5 Recent Developments
20.6 Novartis Ag
20.6.1 Company Snapshot
20.6.2 Revenue Analysis
20.6.3 Product Portfolio
20.6.4 Recent Developments
20.7 Santen Pharmaceutical Co., Ltd.
20.7.1 Company Snapshot
20.7.2 Recent Financials
20.7.3 Product Portfolio
20.7.4 Recent Development
20.8 Akorn Operating Company Llc
20.8.1 Company Snapshot
20.8.2 Product Portfolio
20.8.3 Recent Development
20.9 Amneal Pharmaceuticals Llc.
20.9.1 Company Snapshot
20.9.2 Revenue Analysis
20.9.3 Product Portfolio
20.9.4 Recent Developments
20.10 Eyeris Visioncare Pvt. Ltd.
20.10.1 Company Snapshot
20.10.2 Product Portfolio
20.10.3 Recent Developments
20.11 Maya Biotech Private Limited
20.11.1 Company Snapshot
20.11.2 Product Portfolio
20.11.3 Recent Developments
20.12 Oasis Medical
20.12.1 Company Snapshot
20.12.2 Product Portfolio
20.12.3 Recent Developments
20.13 Prestige Consumer Healthcare Inc.
20.13.1 Company Snapshot
20.13.2 Revenue Analysis
20.13.3 Product Portfolio
20.13.4 Recent Development
20.14 Sager Pharma
20.14.1 Company Snapshot
20.14.2 Product Portfolio
20.14.3 Recent Developments
20.15 Similasan Corporation
20.15.1 Company Snapshot
20.15.2 Product Portfolio
20.15.3 Recent Developments
20.16 Spectra Vision Care
20.16.1 Company Snapshot
20.16.2 Product Portfolio
20.16.3 Recent Developments
20.17 Sylentis
20.17.1 Company Snapshot
20.17.2 Product Portfolio
20.17.3 Recent Development
20.18 Théa Laboratories
20.18.1 Company Snapshot
20.18.2 Product Portfolio
20.18.3 Recent Developments
20.19 Wellona Pharma
20.19.1 Company Snapshot
20.19.2 Product Portfolio
20.19.3 Recent Developments
20.20 Zydus Group
20.20.1 Company Snapshot
20.20.2 Revenue Analysis
20.20.3 Product Portfolio
20.20.4 Recent Developments
21 Questionnaire
22 Related Reports
List Of Tables
Table 1 North America Pterygium Drug Market, Pipeline Analysis
Table 2 North America Pterygium Drug Market, By Disease Type, 2020-2029 (Usd Million)
Table 3 North America Progressive Pterygium In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 4 North America Atrophic Pterygium In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 5 North America Pterygium Drug Market , By Stages, 2020-2029 (Usd Million)
Table 6 North America Stage 2 In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 7 North America Stage 3 In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 8 North America Stage 1 In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 9 North America Stage 4 In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 10 North America Pterygium Drug Market, By Treatment, 2020-2029 (Usd Million)
Table 11 North America Artificial Tears/Topical Lubricants In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 12 North America Artificial Tears/Topical Lubricants In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 13 North America Steroid Eye Drops In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 14 North America Steroid Eye Drops In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 15 North America Ketone Steroids In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 16 North America Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 17 North America Eye Drops In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 18 North America Eye Drops In Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 19 North America Eye Ointments In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 20 North America Others In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 21 North America Pterygium Drug Market, By Mode Of Purchase, 2020-2029 (Usd Million)
Table 22 North America Prescription In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 23 North America Over The Counter (Otc) In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 24 North America Pterygium Drug Market, By Population Type, 2020-2029 (Usd Million)
Table 25 North America Geriatrics In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 26 North America Adults In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 27 North America Pterygium Drug Market, By End User, 2020-2029 (Usd Million)
Table 28 North America Hospitals In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 29 North America Specialty Clinics In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 30 North America Home Healthcare In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 31 North America Others In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 32 North America Pterygium Drug Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 33 North America Retail Pharmacies In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 34 North America Hospital Pharmacies In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 35 North America Online Pharmacies In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 36 North America Others In Pterygium Drug Market, By Region, 2020-2029 (Usd Million)
Table 37 North America Pterygium Drug Market, By Country, 2020-2029 (Usd Million)
Table 38 North America Pterygium Drug Market, By Disease Type, 2020-2029 (Usd Million)
Table 39 North America Pterygium Drug Market, By Stages, 2020-2029 (Usd Million)
Table 40 North America Pterygium Drug Market, By Treatment, 2020-2029 (Usd Million)
Table 41 North America Artificial Tears/Topical Lubricants In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 42 North America Steroids Eye Drops In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 43 North America Ketone Steroids In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 44 North America Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 45 North America Eye Drops In Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 46 North America Pterygium Drug Market, By Mode Of Purchase, 2020-2029 (Usd Million)
Table 47 North America Pterygium Drug Market, By Population Type, 2020-2029 (Usd Million)
Table 48 North America Pterygium Drug Market, By End User, 2020-2029 (Usd Million)
Table 49 North America Pterygium Drug Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 50 U.S. Pterygium Drug Market, By Disease Type, 2020-2029 (Usd Million)
Table 51 U.S. Pterygium Drug Market, By Stages, 2020-2029 (Usd Million)
Table 52 U.S. Pterygium Drug Market, By Treatment, 2020-2029 (Usd Million)
Table 53 U.S. Artificial Tears/Topical Lubricants In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 54 U.S. Steroids Eye Drops In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 55 U.S. Ketone Steroids In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 56 U.S. Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 57 U.S. Eye Drops In Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 58 U.S. Pterygium Drug Market, By Mode Of Purchase, 2020-2029 (Usd Million)
Table 59 U.S. Pterygium Drug Market, By Population Type, 2020-2029 (Usd Million)
Table 60 U.S. Pterygium Drug Market, By End User, 2020-2029 (Usd Million)
Table 61 U.S. Pterygium Drug Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 62 Mexico Pterygium Drug Market, By Disease Type, 2020-2029 (Usd Million)
Table 63 Mexico Pterygium Drug Market, By Stages, 2020-2029 (Usd Million)
Table 64 Mexico Pterygium Drug Market, By Treatment, 2020-2029 (Usd Million)
Table 65 Mexico Artificial Tears/Topical Lubricants In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 66 Mexico Steroids Eye Drops In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 67 Mexico Ketone Steroids In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 68 Mexico Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 69 Mexico Eye Drops In Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 70 Mexico Pterygium Drug Market, By Mode Of Purchase, 2020-2029 (Usd Million)
Table 71 Mexico Pterygium Drug Market, By Population Type, 2020-2029 (Usd Million)
Table 72 Mexico Pterygium Drug Market, By End User, 2020-2029 (Usd Million)
Table 73 Mexico Pterygium Drug Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 74 Canada Pterygium Drug Market, By Disease Type, 2020-2029 (Usd Million)
Table 75 Canada Pterygium Drug Market, By Stages, 2020-2029 (Usd Million)
Table 76 Canada Pterygium Drug Market, By Treatment, 2020-2029 (Usd Million)
Table 77 Canada Artificial Tears/Topical Lubricants In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 78 Canada Steroids Eye Drops In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 79 Canada Ketone Steroids In Pterygium Drug Market, By Type, 2020-2029 (Usd Million)
Table 80 Canada Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 81 Canada Eye Drops In Pterygium Drug Market, By Formulation, 2020-2029 (Usd Million)
Table 82 Canada Pterygium Drug Market, By Mode Of Purchase, 2020-2029 (Usd Million)
Table 83 Canada Pterygium Drug Market, By Population Type, 2020-2029 (Usd Million)
Table 84 Canada Pterygium Drug Market, By End User, 2020-2029 (Usd Million)
Table 85 Canada Pterygium Drug Market, By Distribution Channel, 2020-2029 (Usd Million)
List Of Figures
Figure 1 North America Pterygium Drug Market: Segmentation
Figure 2 North America Pterygium Drug Market: Data Triangulation
Figure 3 North America Pterygium Drug Market: Droc Analysis
Figure 4 North America Pterygium Drug Market: North America Vs Regional Market Analysis
Figure 5 North America Pterygium Drug Market: Company Research Analysis
Figure 6 North America Pterygium Drug Market: Interview Demographics
Figure 7 North America Pterygium Drug Market: Dbmr Position Grid
Figure 8 North America Pterygium Drug Market: Vendor Share Analysis
Figure 9 North America Pterygium Drug Market: End User Coverage Grid
Figure 10 North America Pterygium Drug Market: Segmentation
Figure 11 Asia-pacific Is Anticipated To Dominate The Pterygium Drug Market And Grow With The Highest Cagr In The Forecast Period Of 2022 To 2029
Figure 12 Increasing Prevalence Of Ophthalmic Disorders And Rise In Geriatric Population Are Expected To Drive The North America Pterygium Drug Market From 2022 To 2029
Figure 13 Progressive Pterygium Segment Is Expected To Have The Largest Share Of The North America Pterygium Drug Market From 2022 & 2029
Figure 14 Drivers, Restraints, Opportunities, And Challenges Of The North America Pterygium Drug Market
Figure 15 Ageing Population In The World (In Millions)
Figure 16 North America Pterygium Drug Market: By Disease Type, 2021
Figure 17 North America Pterygium Drug Market: By Disease Type, 2022-2029 (Usd Million)
Figure 18 North America Pterygium Drug Market: By Disease Type, Cagr (2022-2029)
Figure 19 North America Pterygium Drug Market: By Disease Type, Lifeline Curve
Figure 20 North America Pterygium Drug Market: By Stages, 2021
Figure 21 North America Pterygium Drug Market: By Stages, 2022-2029 (Usd Million)
Figure 22 North America Pterygium Drug Market: By Stages, Cagr (2022-2029)
Figure 23 North America Pterygium Drug Market: By Stages, Lifeline Curve
Figure 24 North America Pterygium Drug Market: By Treatment, 2021
Figure 25 North America Pterygium Drug Market: By Treatment, 2022-2029 (Usd Million)
Figure 26 North America Pterygium Drug Market: By Treatment, Cagr (2022-2029)
Figure 27 North America Pterygium Drug Market: By Treatment, Lifeline Curve
Figure 28 North America Pterygium Drug Market: By Formulation, 2021
Figure 29 North America Pterygium Drug Market: By Formulation, 2022-2029 (Usd Million)
Figure 30 North America Pterygium Drug Market: By Formulation, Cagr (2022-2029)
Figure 31 North America Pterygium Drug Market: By Formulation, Lifeline Curve
Figure 32 North America Pterygium Drug Market: By Mode Of Purchase, 2021
Figure 33 North America Pterygium Drug Market: By Mode Of Purchase, 2022-2029 (Usd Million)
Figure 34 North America Pterygium Drug Market: By Mode Of Purchase, Cagr (2022-2029)
Figure 35 North America Pterygium Drug Market: By Mode Of Purchase, Lifeline Curve
Figure 36 North America Pterygium Drug Market: By Population Type, 2021
Figure 37 North America Pterygium Drug Market: By Population Type, 2022-2029 (Usd Million)
Figure 38 North America Pterygium Drug Market: By Population Type, Cagr (2022-2029)
Figure 39 North America Pterygium Drug Market: By Population Type, Lifeline Curve
Figure 40 North America Pterygium Drug Market: By End User, 2021
Figure 41 North America Pterygium Drug Market: By End User, 2022-2029 (Usd Million)
Figure 42 North America Pterygium Drug Market: By End User, Cagr (2022-2029)
Figure 43 North America Pterygium Drug Market: By End User, Lifeline Curve
Figure 44 North America Pterygium Drug Market: By Distribution Channel, 2021
Figure 45 North America Pterygium Drug Market: By Distribution Channel, 2022-2029 (Usd Million)
Figure 46 North America Pterygium Drug Market: By Distribution Channel, Cagr (2022-2029)
Figure 47 North America Pterygium Drug Market: By Distribution Channel, Lifeline Curve
Figure 48 North America Pterygium Drug Market: Snapshot (2021)
Figure 49 North America Pterygium Drug Market: By Country (2021)
Figure 50 North America Pterygium Drug Market: By Country (2022 & 2029)
Figure 51 North America Pterygium Drug Market: By Country (2021 & 2029)
Figure 52 North America Pterygium Drug Market: By Disease Type (2022-2029)
Figure 53 North America Pterygium Drug Market: Company Share 2021 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us